Bristol-Myers Squibb Acquires iPierian for $175M, Potential Milestone Payments of $550M

By: via Benzinga
Advances Discovery Strategy to Pursue Therapeutics for Genetically Defined Diseases Gains Full Rights to IPN007, a Promising ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.